Evidence map›Paper›PMID 40463917›Full record

ArticleFrontiers in health services2025

An iterative approach to evaluating impact of CTSA projects using the translational science benefits model.

Kera Swanson, Nicole A Stadnick, Isaac Bouchard, Zeying Du, Lauren Brookman-Frazee, Gregory A Aarons, Emily Treichler, Maryam Gholami, Borsika A Rabin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kera SwansonUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Nicole A StadnickUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Isaac BouchardUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Zeying DuUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Lauren Brookman-FrazeeUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Gregory A AaronsUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Emily TreichlerUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.
Maryam GholamiUC San Diego Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla, CA, United States.
Borsika A RabinUC San Diego Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center, University of California San Diego, La Jolla, CA, United States.

Funding

Enhancing team effectiveness for a collaborative school-based intervention for ADHDP50MH126231 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GREGORY AARONS, LAUREN BROOKMAN-FRAZEE · 2022 to 2026
$13.9M
NIMH NIH HHS P50 MH126231
6 · The paper itself

Abstract

Introduction: Demonstrating the relevance and impact of translational research across diverse settings is crucial making the research-to-practice pipeline more efficient. The Translational Science Benefits Model (TSBM) is a framework used to report societal and health impacts of clinical and translational research. Methods: A four-phase process was used to co-develop 12 TSBM Impact Profiles aimed at evaluating the impact of clinical and translational research and disseminating this information among diverse audiences. Content analysis was used to understand common and unique themes related to the TSBM domains and benefits across 12 projects. Results: Across the 12 TSBM Impact Profiles, TSBM benefits covered all four TSBM domains (Clinical, Community, Economic, and Policy), with a notable focus on Clinical and Community-related benefits. TSBM Impact Profiles took an average of 9 h to complete, with each phase taking 1-3 h to complete. Common themes included Clinical Innovation and Care Integration, Advancing Health Equity and Accessibility, Community and Stakeholder Engagement, and Policy and Systems-Level Change. Three case exemplars that contextualize findings from the content analysis are presented. Conclusion: This work validates and extends the processes originally developed by the creators of the TSBM and offers a process-oriented example of its successful application at an external institution & CTSA hub. Co-creating TSBM Impact Profiles and documenting their development ensured that information was synthesized for broad dissemination and accessibility. Results highlight an effective process for capturing a multitude of impacts and benefits across diverse research projects with future efforts aimed at expanding the application of this method.

Indexed as

clinical and translational sciencedisseminationevaluationimpacttranslational science benefits model (TSBM)

Identifiers

PMID40463917
PMCPMC12129897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.